Inactive Instrument

BrainsWay Ltd. TEL AVIV STOCK EXCHANGE

Equities

BWAY

IL0011007189

Advanced Medical Equipment & Technology

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : BrainsWay Ltd., Q4 2023 Earnings Call, Mar 06, 2024
BrainsWay Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
BrainsWay Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Brainsway Ltd. Provides Earnings Guidance for Full Year 2024 CI
BrainsWay Ltd. Announces New Rotational Field Technology in Two New Feasibility Studies CI
Brainsway Expands Deep Transcranial Magnetic Stimulation Technology in South Korea MT
BrainsWay Ltd. Announces Continued Expansion of Deep TMS in South Korea CI
Brainsway Says Blue Cross Blue Shield of Louisiana Expands Access to Mental-Health Technology MT
Oppenheimer Adjusts Price Target on Brainsway to $6 From $5.50, Maintains Outperform Rating MT
Raymond James Downgrades Brainsway to Market Perform From Outperform MT
Transcript : BrainsWay Ltd., Q3 2023 Earnings Call, Nov 15, 2023
Earnings Flash (BWAY) BRAINSWAY Reports Q3 Revenue $8.3M MT
BrainsWay Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
BrainsWay Ltd. Announces Publishes the First Coverage Recommendations for Smoking Addiction Treatment Using TMS CI
BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS) for Depression CI
Brainsway Receives 10 Orders for Deep Transcranial Magnetic Stimulation MT
BrainsWay Ltd. Broadens Access to Deep TMS for U.S. Military Service Members Through Expanded Partnership with Katie's Way Plus CI
ADRs Advance, Brainsway Ltd. Climbs 14.0% DJ
Brainsway Ltd. Forges Strategic Partnership with Treatment Provider in Northeast U.S CI
SaverOne 2014 Names Omri Hagai Finance Chief MT
BrainsWay Ltd. Expands Access to Deep TMS in Asia Pacific Region CI
ADRs Slump; MOGU Falls 15% DJ
BrainsWay Ltd. Reiterates Earnings Guidance for the Year 2023 CI
Transcript : BrainsWay Ltd., Q2 2023 Earnings Call, Aug 09, 2023
BrainsWay Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Chart BrainsWay Ltd.
More charts
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
More about the company
  1. Stock
  2. Equities
  3. Stock BrainsWay Ltd.
  4. Stock BrainsWay Ltd. - TEL AVIV STOCK EXCHANGE
  5. News BrainsWay Ltd.
  6. Brainsway Says Cigna Issued 'Favorable Policy' for Obsessive-Compulsive Disorder Treatment